South & Central America Acute Pancreatitis Market Forecast to 2030 – Regional Analysis – by Offerings (Medications, Diagnosis, and Others), Causes (Gallstones, Alcoholism, Genetic Disorders, Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others)
The South & Central America acute pancreatitis market was valued at US$ 209.04 million in 2022 and is expected to reach US$ 333.67 million by 2030; it is estimated to grow at a CAGR of 6.0% from 2022 to 2030.
Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the South & Central America Acute Pancreatitis Market
Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.
Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. The National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), formed a collaborative network of 10 clinical centers and 1 data coordination center in 2020 to address several knowledge gaps regarding acute pancreatitis. The consortium is referred to as Type 1 Diabetes after Acute Pancreatitis Consortium (T1DAPC). Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the South & Central America acute pancreatitis market.
South & Central America Acute Pancreatitis Market Overview
The South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. Increasing in geriatric population in the region and increase in cases of acute pancreatitis is fueling the growth of the South & Central America acute pancreatitis market in the region. Acute pancreatitis is a life-threatening disease, especially in the geriatric population due to co-morbidities and compromised body systems. As per Brazil's Ministry of Health, by 2030, Brazil is anticipated to rank fifth in terms of geriatric population worldwide. The WHO estimated that the elderly population will have increased by more than 300% and the overall population will grow by 30% by 2050 in the country. According to Pan American Health Organization (PAHO), in 2022, Brazil had more than 30 million people aged above 60, which represents 30% of the total population. The number of people aged above 60 is expected to reach ~50 million, which is expected to represent 24% of the total population of Brazil by 2050. Apart from aging, alcohol consumption can also cause acute pancreatitis. According to an article published in Nature, 85.2% of the total alcohol drinkers were heavy drinkers in Brazil. Thus, the increase in alcohol consumption in Brazil is also fueling the growth of the South & Central America acute pancreatitis market.
South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
South & Central America Acute Pancreatitis Market Segmentation
The South & Central America acute pancreatitis market is segmented offerings, causes, end user, and country.
Based on offerings, the South & Central America acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.
Based on causes, the South & Central America acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.
Based on end user, the South & Central America acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.
Based on country, the South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America acute pancreatitis market share in 2022.
Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the South & Central America acute pancreatitis market.
Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the South & Central America Acute Pancreatitis Market
Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.
Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. The National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), formed a collaborative network of 10 clinical centers and 1 data coordination center in 2020 to address several knowledge gaps regarding acute pancreatitis. The consortium is referred to as Type 1 Diabetes after Acute Pancreatitis Consortium (T1DAPC). Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the South & Central America acute pancreatitis market.
South & Central America Acute Pancreatitis Market Overview
The South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. Increasing in geriatric population in the region and increase in cases of acute pancreatitis is fueling the growth of the South & Central America acute pancreatitis market in the region. Acute pancreatitis is a life-threatening disease, especially in the geriatric population due to co-morbidities and compromised body systems. As per Brazil's Ministry of Health, by 2030, Brazil is anticipated to rank fifth in terms of geriatric population worldwide. The WHO estimated that the elderly population will have increased by more than 300% and the overall population will grow by 30% by 2050 in the country. According to Pan American Health Organization (PAHO), in 2022, Brazil had more than 30 million people aged above 60, which represents 30% of the total population. The number of people aged above 60 is expected to reach ~50 million, which is expected to represent 24% of the total population of Brazil by 2050. Apart from aging, alcohol consumption can also cause acute pancreatitis. According to an article published in Nature, 85.2% of the total alcohol drinkers were heavy drinkers in Brazil. Thus, the increase in alcohol consumption in Brazil is also fueling the growth of the South & Central America acute pancreatitis market.
South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
South & Central America Acute Pancreatitis Market Segmentation
The South & Central America acute pancreatitis market is segmented offerings, causes, end user, and country.
Based on offerings, the South & Central America acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.
Based on causes, the South & Central America acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.
Based on end user, the South & Central America acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.
Based on country, the South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America acute pancreatitis market share in 2022.
Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the South & Central America acute pancreatitis market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 South & Central America Acute Pancreatitis Market, by Country (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET LANDSCAPE
4.1 Overview
5. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:
6. ACUTE PANCREATITIS MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
7. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET – REVENUE AND FORECAST TO 2030 – BY OFFERINGS
7.1 Overview
7.2 South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
7.3.1 Overview
7.3.2 Medications: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 South & Central America Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)
7.4 Diagnosis
7.4.1 Overview
7.4.2 Diagnosis: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 South & Central America Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET – REVENUE AND FORECAST TO 2030 – BY CAUSES
8.1 Overview
8.2 South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
8.3.1 Overview
8.3.2 Gallstones: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
8.4.1 Overview
8.4.2 Alcoholism: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
8.5.1 Overview
8.5.2 Genetic Disorders: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
8.6.1 Overview
8.6.2 Infections: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
9.1 Overview
9.2 South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
10. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET - COUNTRY ANALYSIS
10.1 Overview
10.1.1.1 South & Central America Acute Pancreatitis Market, by Country
10.1.1.2 Brazil
10.1.1.2.1 Overview
10.1.1.2.2 Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Brazil: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.1 Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.2 Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.2.4 Brazil: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.2.5 Brazil: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Argentina
10.1.1.3.1 Overview
10.1.1.3.2 Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Argentina: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.1 Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.2 Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.3.4 Argentina: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.3.5 Argentina: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.4 Rest of South & Central America
10.1.1.4.1 Overview
10.1.1.4.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.1 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.4.4 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.4.5 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
11. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET–INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the South & Central America Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Samsung Healthcare
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Baxter International Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medtronic Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Boston Scientific Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Fresenius Kabi AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 South & Central America Acute Pancreatitis Market, by Country (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET LANDSCAPE
4.1 Overview
5. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:
6. ACUTE PANCREATITIS MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
7. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET – REVENUE AND FORECAST TO 2030 – BY OFFERINGS
7.1 Overview
7.2 South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
7.3.1 Overview
7.3.2 Medications: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 South & Central America Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)
7.4 Diagnosis
7.4.1 Overview
7.4.2 Diagnosis: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 South & Central America Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET – REVENUE AND FORECAST TO 2030 – BY CAUSES
8.1 Overview
8.2 South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
8.3.1 Overview
8.3.2 Gallstones: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
8.4.1 Overview
8.4.2 Alcoholism: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
8.5.1 Overview
8.5.2 Genetic Disorders: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
8.6.1 Overview
8.6.2 Infections: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET – REVENUE AND FORECAST TO 2030 – BY END USER
9.1 Overview
9.2 South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
10. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET - COUNTRY ANALYSIS
10.1 Overview
10.1.1.1 South & Central America Acute Pancreatitis Market, by Country
10.1.1.2 Brazil
10.1.1.2.1 Overview
10.1.1.2.2 Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Brazil: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.1 Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.2 Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.2.4 Brazil: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.2.5 Brazil: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Argentina
10.1.1.3.1 Overview
10.1.1.3.2 Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Argentina: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.1 Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.2 Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.3.4 Argentina: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.3.5 Argentina: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.4 Rest of South & Central America
10.1.1.4.1 Overview
10.1.1.4.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.1 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.4.4 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.4.5 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
11. SOUTH & CENTRAL AMERICA ACUTE PANCREATITIS MARKET–INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in the South & Central America Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Samsung Healthcare
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Baxter International Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medtronic Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Boston Scientific Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Fresenius Kabi AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
